Reslizumab and eosinophilic asthma: One step closer to precision medicine?

G. Varricchi, G. Senna, S. Loffredo, D. Bagnasco, M. Ferrando, G.W. Canonica

Research output: Contribution to journalArticle

Original languageEnglish
JournalFrontiers in Immunology
Volume8
Issue numberMAR
DOIs
Publication statusPublished - 2017

Cite this

Reslizumab and eosinophilic asthma: One step closer to precision medicine? / Varricchi, G.; Senna, G.; Loffredo, S.; Bagnasco, D.; Ferrando, M.; Canonica, G.W.

In: Frontiers in Immunology, Vol. 8, No. MAR, 2017.

Research output: Contribution to journalArticle

Varricchi, G. ; Senna, G. ; Loffredo, S. ; Bagnasco, D. ; Ferrando, M. ; Canonica, G.W. / Reslizumab and eosinophilic asthma: One step closer to precision medicine?. In: Frontiers in Immunology. 2017 ; Vol. 8, No. MAR.
@article{f581a43fc59e4144a9ac08da3d104617,
title = "Reslizumab and eosinophilic asthma: One step closer to precision medicine?",
author = "G. Varricchi and G. Senna and S. Loffredo and D. Bagnasco and M. Ferrando and G.W. Canonica",
year = "2017",
doi = "10.3389/fimmu.2017.00242",
language = "English",
volume = "8",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S.A.",
number = "MAR",

}

TY - JOUR

T1 - Reslizumab and eosinophilic asthma: One step closer to precision medicine?

AU - Varricchi, G.

AU - Senna, G.

AU - Loffredo, S.

AU - Bagnasco, D.

AU - Ferrando, M.

AU - Canonica, G.W.

PY - 2017

Y1 - 2017

U2 - 10.3389/fimmu.2017.00242

DO - 10.3389/fimmu.2017.00242

M3 - Article

C2 - 28344579

VL - 8

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - MAR

ER -